Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Febuxostat 40 mg QD	8
Overall Study	STARTED	Febuxostat 80 mg QD	79
Overall Study	STARTED	Febuxostat 120 mg QD	29
Overall Study	STARTED	Total Febuxostat	116
Overall Study	COMPLETED	Febuxostat 40 mg QD	6
Overall Study	COMPLETED	Febuxostat 80 mg QD	41
Overall Study	COMPLETED	Febuxostat 120 mg QD	11
Overall Study	COMPLETED	Total Febuxostat	58
Overall Study	NOT COMPLETED	Febuxostat 40 mg QD	2
Overall Study	NOT COMPLETED	Febuxostat 80 mg QD	38
Overall Study	NOT COMPLETED	Febuxostat 120 mg QD	18
Overall Study	NOT COMPLETED	Total Febuxostat	58

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00174941/flow